Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
specificStage IA includes: (T1a, N0, M0); (T1b, N0, M0). T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)
6
Centers
5
Active Trials
—
Cancer Funding
Top Centers for Pathologic Stage IIIA Cutaneous Melanoma AJCC v8(6)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 62.1 |
| 2 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 62.1 |
| 3 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 62.1 |
| 4 | University of Illinois Cancer CenterChicago, IL Active Research Program | 62.1 |
| 5 | Boston University Cancer CenterBoston, MA Active Research Program | 62.1 |
| 6 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 39.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →